Statistics for Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)

Total visits

views
Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance) 218

Total visits per month

views
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0
December 2024 0

File Visits

views
JCO661595.pdf 215

Top country views

views
United States 177
Germany 9
Ukraine 6
Canada 4
Russia 4
China 2
United Kingdom 2
Malaysia 1

Top city views

views
Wilmington 52
Fairfield 31
Houston 21
Ann Arbor 9
Jacksonville 7
Cambridge 6
Kiez 6
Kiev 5
Toronto 4
Lake Mary 3
Saint Petersburg 3
Baltimore 2
Beijing 2
Gunzenhausen 2
San Francisco 2
Costa Mesa 1
Indianapolis 1
Kharkov 1
Liversedge 1
Moscow 1
New York 1
Philadelphia 1
Plauen 1
Scottsdale 1
Seremban 1